Drug-induced oral lichenoid reaction during nivolumab therapy
Author:
Publisher
Elsevier BV
Subject
Otorhinolaryngology,Oral Surgery,Surgery
Reference10 articles.
1. Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy;Hofmann;Eur J Cancer,2016
2. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies;Naidoo;Ann Oncol,2015
3. Clinical and histologic features of lichenoid mucocutaneous eruptions due to anti-programmed cell death 1 and anti-programmed cell death ligand 1 immunotherapy;Shi;JAMA Dermatol,2016
4. Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort;Hwang;J Am Acad Dermatol,2016
5. Cytotoxic cutaneous adverse drug reactions during anti-PD-1 therapy;Goldinger;Clin Cancer Res,2016
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Oral lichenoid lesions as an immune‐related adverse event: A rare case report and literature review;Oral Science International;2024-09-07
2. Oral Toxicities Associated with Immune Checkpoint Inhibitors: Meta-Analyses of Clinical Trials;Journal of Immunotherapy and Precision Oncology;2024-02-01
3. Lichenoid mucocutaneous reactions associated with sintilimab therapy in a non-small cell lung adenocarcinoma patient: case report and review;Frontiers in Pharmacology;2023-12-12
4. Lesions in the oral mucosa associated with the use of checkpoint inhibitors: A bibliometric and critical review;Special Care in Dentistry;2023-06-07
5. Lichenoid drug reaction after ipilimumab/nivolumab combination therapy: A case report;SAGE Open Medical Case Reports;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3